Stephens analyst has initiated coverage on ADC Therapeutics SA (NYSE:ADCT), a commercial-stage oncology-focused biotechnology company developing antibody-drug conjugates (ADCs) for patients with ...
The GHSA-endorsed competitive-balance reclassification model needs to make up lost ground Monday when the GHSA’s reclass committee resumes its monthly meetings in Thomaston. The meeting agenda, which ...
In a Washington policy landscape increasingly dominated by calls for minimal AI regulation, Hugging Face is making a distinctly different case to the Trump administration: open-source and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results